Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-03-19 @ 3:52 PM
Study NCT ID:
NCT00082095
Status:
TERMINATED
Last Update Posted:
2014-10-09
First Post:
2004-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR004645
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |